NCT06232044 Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT06205485 Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer Status RECRUITING Phase PHASE3
NCT05976763 Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma Status RECRUITING Phase PHASE3
NCT05812807 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab Status RECRUITING Phase PHASE3
NCT05751668 Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) Status SUSPENDED Phase PHASE2
NCT05710406 Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05705401 Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05694871 Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05677490 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma Status RECRUITING Phase PHASE3
NCT05673148 Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study Status RECRUITING Phase PHASE3
NCT05647265 Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma Status RECRUITING Phase PHASE2
NCT05451004 SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer Status RECRUITING Phase PHASE3
NCT05379153 Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial Status RECRUITING Phase PHASE3
NCT05334069 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection Status RECRUITING Phase N/A
NCT05303792 Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05008848 Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program Status RECRUITING Phase PHASE3
NCT04939090 Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04803201 Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma Status RECRUITING Phase PHASE2
NCT04457596 T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04242095 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects Status RECRUITING Phase N/A